This episode will focus on reviewing the role of an emergency medicine pharmacist, as well as characteristics of an emergency medicine pharmacist that will help them succeed in their practice. CE for this episode expires 2 years after the date it was originally published.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to inform listeners about opportunities and concerns in the pharmacy leadership pipeline across hospitals and health systems. Most health-system pharmacy leaders are satisfied with their decision to pursue leadership; however, many also identify opportunities for improvement, including leadership development and growth opportunities, mentorship, and work-life balance. The development of the pipeline for residents, mid-level managers, and upper-level pharmacy executives is also explored.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The second in a five-part series, this episode of Tools of The Trade covers different options for data ingestion.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy services can impact various facets of healthcare, including improved patient outcomes, enhanced quality and safety measures, and significant cost avoidance or reduction. Join a panel of key leaders as they share insights on identifying, quantifying, and communicating the value and impact of clinical pharmacy services.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast discusses the side effects of GLP-1 agonists and the potential for drug-drug interactions. The episode also includes a discussion on how best to manage these issues when they arise.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Despite the passage of the Inflation Reduction Act, drug prices continue to rise. How are manufacturers using the patent, drug approval process, and courts to keep drug prices high, and what are the legislative solutions to these practices?

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This is second in a two-part feature on emergency medicine presentations from the ASHP Midyear Clinical Meeting. Members highlight topics such as sedation and analgesia in the setting of procedural sedation, managing patients in the emergency department in small and rural settings, and how to read and interpret echocardiograms.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As questions about vaccines, evolving recommendations, and public health policy continue to grow, healthcare professionals and patients alike are seeking trusted information and guidance. In this episode, ASHP Executive Vice President and CEO Sam Calabrese is joined by Anna Legreid Dopp and Vicki Basalyga to discuss ASHP's position on vaccines, the advocacy and partnership efforts underway, and the resources available to support pharmacists and patients. Tune in for a conversation about how pharmacy professionals can help advance evidence-based patient care and informed decision-making.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.